# PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPC

> **NCT07235319** · PHASE3 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 260 (estimated)

## Conditions studied

- Nasopharangeal Cancer
- Distant Metastasis

## Interventions

- **RADIATION:** Immediate locoregional radiotherapy
- **RADIATION:** Salvage locoregional radiotherapy

## Key facts

- **NCT ID:** NCT07235319
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-20
- **Primary completion:** 2031-11-20
- **Final completion:** 2034-11-20
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07235319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07235319, "PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Salvage Locoregional Radiotherapy in De Novo Metastatic NPC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07235319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*